Advertisement

Isolation and Molecular Characterization of Progenitor Cells from Human Umbilical Cord

  • Umesh Goyal
  • Ankita Sen
  • Malancha TaEmail author
Protocol
Part of the Methods in Molecular Biology book series (MIMB, volume 2029)

Abstract

Mesenchymal stem cells (MSCs) are multipotent precursor cells which have been isolated from different vascularized tissue sources. Due to their paracrine function of secreting trophic and immunomodulatory molecules, MSCs are successfully used in cell-based transplantations and provide an alternative medical paradigm for treating a variety of devastating disorders. Umbilical cord is a medical waste with a large, readily available donor pool. Since umbilical cord is a fetal tissue, MSCs derived from it are considered more primitive with proliferative and differentiation advantages over adult MSCs. We define here a simple, efficient, and reproducible protocol to isolate MSCs from WJ of human umbilical cord using a nonenzymatic procedure. Under the optimized culture conditions, the WJ-MSCs undergo robust proliferation, can be expanded up to 15–20 passages and express the characteristic MSC surface antigens. They can be differentiated into mesodermal lineages in vitro.

Key words

Wharton’s jelly Mesenchymal stem cells Explant culture Umbilical cord Arteries Flow cytometry 

Notes

Acknowledgments

This work was financially supported by SERB, DST, India. We are thankful to Dr. Jayanta Chatterjee, Aastha, Kalyani, for generously providing us with human umbilical cord samples. We thank CSIR and UGC India for the fellowship of Mr. Umesh Goyal and Ms. Ankita Sen, respectively.

References

  1. 1.
    Caplan AI (2017) Mesenchymal stem cells: time to change the name! Stem Cells Transl Med 6:1445–1451CrossRefGoogle Scholar
  2. 2.
    da Silva Meirelles L, Chagastelles PC, Nardi NB (2006) Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci 119:2204–2213CrossRefGoogle Scholar
  3. 3.
    Hass R, Kasper C, Böhm S, Jacobs R (2011) Different populations and sources of human mesenchymal stem cells (MSC): a comparison of adult and neonatal tissue-derived MSC. Cell Commun Signal 9:12CrossRefGoogle Scholar
  4. 4.
    Batsali AK, Kastrinaki MC, Papadaki HA, Pontikoglou C (2013) Mesenchymal stem cells derived from Wharton’s jelly of the umbilical cord: biological properties and emerging clinical applications. Curr Stem Cell Res Ther 8:144–155CrossRefGoogle Scholar
  5. 5.
    El Omar R, Beroud J, Stoltz JF, Menu P, Velot E, Decot V (2014) Umbilical cord mesenchymal stem cells: the new gold standard for mesenchymal stem cell-based therapies? Tissue Eng Part B Rev 20:523–544CrossRefGoogle Scholar
  6. 6.
    Dalous J, Larghero J, Baud O (2012) Transplantation of umbilical cord-derived mesenchymal stem cells as a novel strategy to protect the central nervous system: technical aspects, preclinical studies, and clinical perspectives. Pediatr Res 71:482–490CrossRefGoogle Scholar
  7. 7.
    Troyer DL, Weiss ML (2008) Wharton’s jelly-derived cells are a primitive stromal cell population. Stem Cells 26:591–599CrossRefGoogle Scholar
  8. 8.
    Kalaszczynska I, Ferdyn K (2015) Wharton’s jelly derived mesenchymal stem cells: future of regenerative medicine? Recent findings and clinical significance. Biomed Res Int 2015:430847CrossRefGoogle Scholar
  9. 9.
    Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Dj P, Horwitz E (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315–317PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Indian Institute of Science Education and ResearchKolkataIndia

Personalised recommendations